The value of vedolizumab as rescue therapy in moderate-severe Crohn's disease patients with adalimumab non-response in the USA
Erim, DO., Mahendraratnam, N., Okafor, PN., & Wheeler, SB. (2015). The value of vedolizumab as rescue therapy in moderate-severe Crohn's disease patients with adalimumab non-response in the USA. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjv090
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.